Serbia

Hepatitis B

Download HBV data

Prevalence of chronic HBV (HBsAg+)

National

Download

Value (%)	Year	Type	Source
0.7 (0.60 - 0.81)	2019	Modelled	IHME
0.7 (0.60 - 0.79)	2018	Modelled	IHME
0.7 (0.60 - 0.80)	2017	Modelled	IHME
0.71 (0.61 - 0.81)	2016	Modelled	IHME
0.73 (0.62 - 0.84)	2015	Modelled	IHME
0.75 (0.64 - 0.85)	2014	Modelled	IHME
0.76 (0.65 - 0.86)	2013	Modelled	IHME
0.78 (0.67 - 0.88)	2012	Modelled	IHME
0.8 (0.67 - 0.91)	2011	Modelled	IHME
0.81 (0.68 - 0.93)	2010	Modelled	IHME
0.83 (0.70 - 0.94)	2009	Modelled	IHME
0.84 (0.71 - 0.97)	2008	Modelled	IHME
0.85 (0.72 - 0.98)	2007	Modelled	IHME
0.87 (0.74 - 1)	2006	Modelled	IHME
0.88 (0.74 - 1.02)	2005	Modelled	IHME
0.89 (0.76 - 1.02)	2004	Modelled	IHME
0.9 (0.77 - 1.03)	2003	Modelled	IHME
0.91 (0.78 - 1.04)	2002	Modelled	IHME
0.92 (0.78 - 1.05)	2001	Modelled	IHME
0.93 (0.79 - 1.06)	2000	Modelled	IHME
0.94 (0.80 - 1.07)	1999	Modelled	IHME
0.95 (0.81 - 1.08)	1998	Modelled	IHME
0.96 (0.81 - 1.10)	1997	Modelled	IHME
0.97 (0.82 - 1.11)	1996	Modelled	IHME
0.97 (0.81 - 1.12)	1995	Modelled	IHME
0.97 (0.81 - 1.12)	1994	Modelled	IHME
0.97 (0.81 - 1.11)	1993	Modelled	IHME
0.96 (0.81 - 1.10)	1992	Modelled	IHME
0.95 (0.80 - 1.10)	1991	Modelled	IHME
0.94 (0.78 - 1.08)	1990	Modelled	IHME
0.98 (0.70 - 1.33)	2015	Modelled	WHO

Showing out of

Children under-5 years

Download

Value (%)	Year	Type	Source
0.06 (0.04 - 0.08)	2019	Modelled	IHME
0.07 (0.05 - 0.09)	2018	Modelled	IHME
0.07 (0.05 - 0.09)	2017	Modelled	IHME
0.06 (0.05 - 0.08)	2016	Modelled	IHME
0.06 (0.04 - 0.08)	2015	Modelled	IHME
0.06 (0.04 - 0.08)	2014	Modelled	IHME
0.06 (0.04 - 0.07)	2013	Modelled	IHME
0.06 (0.04 - 0.07)	2012	Modelled	IHME
0.06 (0.04 - 0.07)	2011	Modelled	IHME
0.06 (0.04 - 0.07)	2010	Modelled	IHME
0.06 (0.05 - 0.08)	2009	Modelled	IHME
0.08 (0.06 - 0.11)	2008	Modelled	IHME
0.11 (0.08 - 0.15)	2007	Modelled	IHME
0.15 (0.11 - 0.20)	2006	Modelled	IHME
0.19 (0.14 - 0.25)	2005	Modelled	IHME
0.25 (0.18 - 0.33)	2004	Modelled	IHME
0.34 (0.25 - 0.44)	2003	Modelled	IHME
0.44 (0.32 - 0.57)	2002	Modelled	IHME
0.52 (0.38 - 0.67)	2001	Modelled	IHME
0.57 (0.41 - 0.74)	2000	Modelled	IHME
0.58 (0.42 - 0.76)	1999	Modelled	IHME
0.6 (0.43 - 0.78)	1998	Modelled	IHME
0.61 (0.44 - 0.80)	1997	Modelled	IHME
0.61 (0.44 - 0.82)	1996	Modelled	IHME
0.61 (0.44 - 0.83)	1995	Modelled	IHME
0.61 (0.44 - 0.82)	1994	Modelled	IHME
0.61 (0.43 - 0.80)	1993	Modelled	IHME
0.6 (0.42 - 0.80)	1992	Modelled	IHME
0.59 (0.41 - 0.79)	1991	Modelled	IHME
0.57 (0.39 - 0.76)	1990	Modelled	IHME
0.11 (0.06 - 0.17)	2015	Modelled	WHO

Showing out of

HBV-related death rate

National

Download

Value (per 100,000)	Year	Type	Source
4.64 (3.31 - 6.32)	2019	Modelled	IHME
4.56 (3.29 - 6.16)	2018	Modelled	IHME
4.52 (3.39 - 5.99)	2017	Modelled	IHME
4.62 (3.60 - 5.89)	2016	Modelled	IHME
4.97 (3.90 - 6.38)	2015	Modelled	IHME
5.35 (4.19 - 6.81)	2014	Modelled	IHME
5.82 (4.59 - 7.36)	2013	Modelled	IHME
6.36 (5.01 - 7.97)	2012	Modelled	IHME
6.83 (5.40 - 8.50)	2011	Modelled	IHME
7.15 (5.70 - 8.82)	2010	Modelled	IHME
7.41 (5.93 - 9.10)	2009	Modelled	IHME
7.59 (6.07 - 9.33)	2008	Modelled	IHME
7.57 (6.05 - 9.21)	2007	Modelled	IHME
7.62 (6.12 - 9.32)	2006	Modelled	IHME
7.65 (6.16 - 9.38)	2005	Modelled	IHME
7.54 (6.07 - 9.20)	2004	Modelled	IHME
7.43 (5.94 - 9.04)	2003	Modelled	IHME
7.32 (5.85 - 8.95)	2002	Modelled	IHME
7.34 (5.89 - 8.94)	2001	Modelled	IHME
7.38 (5.88 - 9.04)	2000	Modelled	IHME
7.31 (5.84 - 8.98)	1999	Modelled	IHME
7.44 (5.96 - 9.14)	1998	Modelled	IHME
7.68 (6.11 - 9.55)	1997	Modelled	IHME
7.33 (5.82 - 9.06)	1996	Modelled	IHME
7.14 (5.62 - 8.81)	1995	Modelled	IHME
6.95 (5.27 - 8.82)	1994	Modelled	IHME
6.77 (4.95 - 8.83)	1993	Modelled	IHME
6.56 (4.74 - 8.52)	1992	Modelled	IHME
6.44 (4.79 - 8.29)	1991	Modelled	IHME
6.54 (4.95 - 8.30)	1990	Modelled	IHME

Showing out of

Technical notes

HBV-related deaths

National

Download

Value	Year	Type	Source
406 (289 - 553)	2019	Modelled	IHME
401 (289 - 541)	2018	Modelled	IHME
399 (299 - 528)	2017	Modelled	IHME
409 (319 - 522)	2016	Modelled	IHME
441 (346 - 567)	2015	Modelled	IHME
476 (373 - 606)	2014	Modelled	IHME
521 (411 - 658)	2013	Modelled	IHME
571 (450 - 715)	2012	Modelled	IHME
614 (485 - 763)	2011	Modelled	IHME
643 (513 - 794)	2010	Modelled	IHME
669 (535 - 822)	2009	Modelled	IHME
689 (551 - 847)	2008	Modelled	IHME
692 (553 - 842)	2007	Modelled	IHME
701 (563 - 857)	2006	Modelled	IHME
708 (570 - 867)	2005	Modelled	IHME
702 (565 - 857)	2004	Modelled	IHME
697 (557 - 848)	2003	Modelled	IHME
688 (550 - 840)	2002	Modelled	IHME
695 (558 - 846)	2001	Modelled	IHME
706 (563 - 866)	2000	Modelled	IHME
689 (550 - 846)	1999	Modelled	IHME
692 (554 - 850)	1998	Modelled	IHME
736 (586 - 915)	1997	Modelled	IHME
720 (572 - 889)	1996	Modelled	IHME
702 (553 - 867)	1995	Modelled	IHME
683 (518 - 867)	1994	Modelled	IHME
660 (483 - 861)	1993	Modelled	IHME
637 (461 - 829)	1992	Modelled	IHME
619 (461 - 797)	1991	Modelled	IHME
614 (465 - 780)	1990	Modelled	IHME
304	2016	Modelled	WHO

Showing out of

Technical notes

Percent of liver cancer deaths attributable to HBV

National

Download

Value (%)	Year	Type	Source
18 (12 - 25)	2019	Modelled	IHME
18 (12 - 25)	2018	Modelled	IHME
18 (12 - 25)	2017	Modelled	IHME
18 (12 - 25)	2016	Modelled	IHME
18 (13 - 26)	2015	Modelled	IHME
19 (13 - 26)	2014	Modelled	IHME
19 (14 - 27)	2013	Modelled	IHME
20 (14 - 28)	2012	Modelled	IHME
20 (14 - 28)	2011	Modelled	IHME
21 (15 - 29)	2010	Modelled	IHME
21 (15 - 29)	2009	Modelled	IHME
21 (15 - 29)	2008	Modelled	IHME
21 (15 - 29)	2007	Modelled	IHME
21 (15 - 29)	2006	Modelled	IHME
21 (15 - 29)	2005	Modelled	IHME
21 (15 - 29)	2004	Modelled	IHME
22 (15 - 30)	2003	Modelled	IHME
22 (15 - 30)	2002	Modelled	IHME
22 (15 - 30)	2001	Modelled	IHME
22 (15 - 31)	2000	Modelled	IHME
22 (15 - 31)	1999	Modelled	IHME
22 (15 - 31)	1998	Modelled	IHME
22 (16 - 31)	1997	Modelled	IHME
23 (16 - 31)	1996	Modelled	IHME
23 (16 - 31)	1995	Modelled	IHME
23 (16 - 32)	1994	Modelled	IHME
23 (16 - 32)	1993	Modelled	IHME
23 (16 - 32)	1992	Modelled	IHME
23 (16 - 32)	1991	Modelled	IHME
23 (16 - 32)	1990	Modelled	IHME

Showing out of

Technical notes

Coverage of HepB birth dose

Newborns

Download

Value (%)	Year	Type	Source
99	2018	Survey/reported	WHO/UNICEF
99	2017	Survey/reported	WHO/UNICEF
99	2016	Survey/reported	WHO/UNICEF
99	2015	Survey/reported	WHO/UNICEF
99	2014	Survey/reported	WHO/UNICEF
99	2013	Survey/reported	WHO/UNICEF
99	2012	Survey/reported	WHO/UNICEF
99	2011	Survey/reported	WHO/UNICEF
99	2010	Survey/reported	WHO/UNICEF
99	2009	Survey/reported	WHO/UNICEF
99	2008	Survey/reported	WHO/UNICEF
99	2007	Survey/reported	WHO/UNICEF
98	2006	Survey/reported	WHO/UNICEF
98	2005	Survey/reported	WHO/UNICEF
98	2004	Survey/reported	WHO/UNICEF

Showing out of

Technical notes

Coverage of 3-dose hepatitis B vaccine

Infants

Download

Value (%)	Year	Type	Source
91	2018	Survey/reported	WHO/UNICEF
93	2017	Survey/reported	WHO/UNICEF
91	2016	Survey/reported	WHO/UNICEF
94	2015	Survey/reported	WHO/UNICEF
92	2014	Survey/reported	WHO/UNICEF
91	2013	Survey/reported	WHO/UNICEF
97	2012	Survey/reported	WHO/UNICEF
94	2011	Survey/reported	WHO/UNICEF
89	2010	Survey/reported	WHO/UNICEF
93	2009	Survey/reported	WHO/UNICEF
93	2008	Survey/reported	WHO/UNICEF
99	2007	Survey/reported	WHO/UNICEF
93	2006	Survey/reported	WHO/UNICEF
65	2005	Survey/reported	WHO/UNICEF
89	2004	Survey/reported	WHO/UNICEF

Showing out of

Percent of PWID accessing OST

People who inject drugs (PWID)

Download

Value (%)	Year	Type	Source
4 (2.60 - 6)	2010	Survey/reported	EMCDDA, 2016

HBV National Action Plan

HBV elimination goal

HepB birth dose policy

Yes

Source: WHO

Year of birth dose introduction

2006

Source: WHO

Eligible for HBV generic medicines

Source: MPP

HCV National Action Plan

HCV elimination goal

Eligible for HCV generic medicines

Source: MPP

At least one needle-syringe exchange program (NSP) operational

Yes

Source: Harm Reduction International

At least one opioid substitution therapy (OST) program operational

Yes

Source: Harm Reduction International

NSP in at least one prison

Source: Harm Reduction International

OST in at least one prison

Yes

Source: Harm Reduction International

Hepatitis C

Download HCV data

Prevalence of chronic HCV (RNA+/cAg)

National

Download

Value (%)	Year	Type	Source
1.11 (0.90 - 1.37)	2019	Modelled	IHME
1.1 (0.90 - 1.36)	2018	Modelled	IHME
1.1 (0.89 - 1.35)	2017	Modelled	IHME
1.09 (0.89 - 1.33)	2016	Modelled	IHME
1.09 (0.89 - 1.32)	2015	Modelled	IHME
1.09 (0.89 - 1.32)	2014	Modelled	IHME
1.1 (0.90 - 1.34)	2013	Modelled	IHME
1.11 (0.90 - 1.36)	2012	Modelled	IHME
1.12 (0.90 - 1.38)	2011	Modelled	IHME
1.13 (0.90 - 1.40)	2010	Modelled	IHME
1.12 (0.90 - 1.38)	2009	Modelled	IHME
1.12 (0.90 - 1.37)	2008	Modelled	IHME
1.11 (0.89 - 1.36)	2007	Modelled	IHME
1.1 (0.89 - 1.34)	2006	Modelled	IHME
1.1 (0.88 - 1.34)	2005	Modelled	IHME
1.1 (0.88 - 1.33)	2004	Modelled	IHME
1.09 (0.88 - 1.33)	2003	Modelled	IHME
1.09 (0.88 - 1.33)	2002	Modelled	IHME
1.09 (0.88 - 1.33)	2001	Modelled	IHME
1.09 (0.88 - 1.33)	2000	Modelled	IHME
1.09 (0.88 - 1.32)	1999	Modelled	IHME
1.08 (0.87 - 1.31)	1998	Modelled	IHME
1.07 (0.86 - 1.30)	1997	Modelled	IHME
1.06 (0.85 - 1.29)	1996	Modelled	IHME
1.05 (0.85 - 1.29)	1995	Modelled	IHME
1.05 (0.84 - 1.28)	1994	Modelled	IHME
1.04 (0.84 - 1.28)	1993	Modelled	IHME
1.04 (0.84 - 1.27)	1992	Modelled	IHME
1.04 (0.84 - 1.27)	1991	Modelled	IHME
1.03 (0.84 - 1.27)	1990	Modelled	IHME

Showing out of

Prevalence of anti-HCV

People who inject drugs (PWID)

Download

Value (%)	Year	Type	Source
25.9 (22.10 - 29.70)	2014	Modelled	Degenhardt L et al, 2017

HCV-related death rate

National

Download

Value (per 100,000)	Year	Type	Source
6.57 (4.66 - 8.85)	2019	Modelled	IHME
6.5 (4.78 - 8.63)	2018	Modelled	IHME
6.39 (4.85 - 8.25)	2017	Modelled	IHME
6.24 (4.92 - 7.70)	2016	Modelled	IHME
6.21 (4.88 - 7.71)	2015	Modelled	IHME
6.22 (4.89 - 7.74)	2014	Modelled	IHME
6.16 (4.81 - 7.66)	2013	Modelled	IHME
6.13 (4.85 - 7.65)	2012	Modelled	IHME
6.17 (4.85 - 7.68)	2011	Modelled	IHME
6.28 (4.92 - 7.79)	2010	Modelled	IHME
6.49 (5.10 - 8.01)	2009	Modelled	IHME
6.61 (5.22 - 8.21)	2008	Modelled	IHME
6.58 (5.22 - 8.13)	2007	Modelled	IHME
6.61 (5.27 - 8.17)	2006	Modelled	IHME
6.6 (5.27 - 8.21)	2005	Modelled	IHME
6.46 (5.15 - 7.98)	2004	Modelled	IHME
6.31 (5.04 - 7.83)	2003	Modelled	IHME
6.18 (4.91 - 7.72)	2002	Modelled	IHME
6.19 (4.87 - 7.66)	2001	Modelled	IHME
6.12 (4.83 - 7.64)	2000	Modelled	IHME
6.06 (4.78 - 7.50)	1999	Modelled	IHME
6.12 (4.77 - 7.63)	1998	Modelled	IHME
6.23 (4.85 - 7.90)	1997	Modelled	IHME
5.91 (4.62 - 7.43)	1996	Modelled	IHME
5.72 (4.49 - 7.20)	1995	Modelled	IHME
5.53 (4.23 - 7.20)	1994	Modelled	IHME
5.36 (3.94 - 7.06)	1993	Modelled	IHME
5.17 (3.76 - 6.85)	1992	Modelled	IHME
5.06 (3.72 - 6.51)	1991	Modelled	IHME
5.13 (3.87 - 6.57)	1990	Modelled	IHME

Showing out of

Technical notes

HCV-related deaths

National

Download

Value	Year	Type	Source
575 (407 - 774)	2019	Modelled	IHME
571 (420 - 758)	2018	Modelled	IHME
564 (428 - 728)	2017	Modelled	IHME
553 (436 - 682)	2016	Modelled	IHME
552 (434 - 685)	2015	Modelled	IHME
554 (435 - 689)	2014	Modelled	IHME
551 (430 - 686)	2013	Modelled	IHME
551 (435 - 687)	2012	Modelled	IHME
554 (436 - 690)	2011	Modelled	IHME
565 (442 - 700)	2010	Modelled	IHME
586 (461 - 724)	2009	Modelled	IHME
601 (474 - 745)	2008	Modelled	IHME
602 (477 - 744)	2007	Modelled	IHME
608 (485 - 752)	2006	Modelled	IHME
610 (487 - 759)	2005	Modelled	IHME
601 (479 - 743)	2004	Modelled	IHME
591 (472 - 734)	2003	Modelled	IHME
580 (461 - 725)	2002	Modelled	IHME
586 (461 - 725)	2001	Modelled	IHME
586 (462 - 731)	2000	Modelled	IHME
571 (450 - 706)	1999	Modelled	IHME
569 (443 - 709)	1998	Modelled	IHME
597 (465 - 757)	1997	Modelled	IHME
580 (454 - 729)	1996	Modelled	IHME
562 (442 - 708)	1995	Modelled	IHME
543 (416 - 707)	1994	Modelled	IHME
523 (384 - 689)	1993	Modelled	IHME
503 (365 - 666)	1992	Modelled	IHME
486 (357 - 625)	1991	Modelled	IHME
482 (364 - 617)	1990	Modelled	IHME
551	2016	Modelled	WHO

Showing out of

Technical notes

Percent of liver cancer deaths attributable to HCV

National

Download

Value (%)	Year	Type	Source
35 (25 - 44)	2019	Modelled	IHME
35 (26 - 44)	2018	Modelled	IHME
35 (26 - 44)	2017	Modelled	IHME
35 (25 - 44)	2016	Modelled	IHME
34 (25 - 44)	2015	Modelled	IHME
34 (25 - 44)	2014	Modelled	IHME
34 (25 - 44)	2013	Modelled	IHME
34 (25 - 43)	2012	Modelled	IHME
34 (24 - 43)	2011	Modelled	IHME
34 (24 - 43)	2010	Modelled	IHME
34 (24 - 43)	2009	Modelled	IHME
34 (24 - 43)	2008	Modelled	IHME
34 (25 - 43)	2007	Modelled	IHME
34 (25 - 43)	2006	Modelled	IHME
34 (25 - 43)	2005	Modelled	IHME
33 (24 - 43)	2004	Modelled	IHME
33 (24 - 43)	2003	Modelled	IHME
33 (24 - 42)	2002	Modelled	IHME
33 (24 - 42)	2001	Modelled	IHME
32 (24 - 42)	2000	Modelled	IHME
33 (24 - 42)	1999	Modelled	IHME
32 (23 - 42)	1998	Modelled	IHME
32 (23 - 42)	1997	Modelled	IHME
32 (23 - 42)	1996	Modelled	IHME
32 (24 - 42)	1995	Modelled	IHME
32 (24 - 42)	1994	Modelled	IHME
32 (23 - 42)	1993	Modelled	IHME
32 (23 - 42)	1992	Modelled	IHME
32 (23 - 41)	1991	Modelled	IHME
32 (23 - 42)	1990	Modelled	IHME

Showing out of

Technical notes

Percent of PWID accessing OST

People who inject drugs (PWID)

Download

Value (%)	Year	Type	Source
4 (2.60 - 6)	2010	Survey/reported	EMCDDA, 2016

HBV National Action Plan

HBV elimination goal

HepB birth dose policy

Yes

Source: WHO

Year of birth dose introduction

2006

Source: WHO

Eligible for HBV generic medicines

Source: MPP

HCV National Action Plan

HCV elimination goal

Eligible for HCV generic medicines

Source: MPP

At least one needle-syringe exchange program (NSP) operational

Yes

Source: Harm Reduction International

At least one opioid substitution therapy (OST) program operational

Yes

Source: Harm Reduction International

NSP in at least one prison

Source: Harm Reduction International

OST in at least one prison

Yes

Source: Harm Reduction International

Overview

HBV elimination goal

HCV elimination goal

Prevalence (national)

Modelled

HBV (HBsAg+)

0.7 (%)

2019

(0.6 - 0.81(%))

IHME

HCV (RNA/cAg+)

1.11 (%)

2019

(0.9 - 1.37(%))

IHME

Survey/surveillance

No data available

Hepatitis related deaths (national)

Modelled

HBV

406

2019

(289 - 553)

IHME

Survey/surveillance

No data available

HBV chart

Modelled

HCV

575

2019

(407 - 774)

IHME

Survey/surveillance

No data available

HCV chart

Prevalence < 5

HBV

0.06 (%)

2019, latest modelled

(0.04 - 0.08(%))

IHME

Prevalence PWID

HCV

25.90 (%)

2014, latest modelled

(22.10 - 29.70(%))

Degenhardt L et al, 2017

Birth dose vaccination coverage (national)

Survey/surveillance

HBV

99 (%)

2018

WHO/UNICEF

No. of syringes/PWID/year

Survey/surveillance

No data available

Eligible for HBV generic medicines

Eligible for HCV generic medicines

Resources

National plans

Action plan for the health sector response to viral hepatitis in the WHO European Region

03 Apr 2017

Hepatitis C Elimination in Europe European Policy Guidelines

01 Nov 2017

Hepatitis B and C Public Policy Association

Hepatitis C